John (Jack) E Shively

Title: John (Jack) E Shively: Innovator in Cancer Treatment

Introduction

John (Jack) E Shively is a prominent inventor based in Duarte, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on targeted therapies that aim to improve patient outcomes in oncology.

Latest Patents

One of his notable patents is for "TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors." This patent describes chimeric antigen receptors targeted to TAG72 and their use in treating ovarian cancer and other cancers. This innovative approach has the potential to revolutionize cancer therapies by providing more effective treatment options for patients.

Career Highlights

John (Jack) E Shively is affiliated with City of Hope, a leading research and treatment center for cancer. His work at this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies. His dedication to improving cancer treatment has made him a respected figure in the medical community.

Collaborations

He has worked alongside notable colleagues such as Saul J Priceman and John P Murad. These collaborations have further enhanced the impact of his research and have contributed to advancements in cancer treatment methodologies.

Conclusion

John (Jack) E Shively is a key innovator in the field of cancer treatment, with a focus on targeted therapies that show promise for improving patient outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science and providing hope to cancer patients.